After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

Ensifentrine is a promising supplementary therapeutic option in the management of chronic obstructive pulmonary disease (COPD), according to systematic review and meta-analysis findings published in ...

Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.

MRI of inhaled perfluoropropane can assess regional lung ventilation and monitor improvements in response to medication ...

In separate, live virtual events, Vincent K. Lam, MD, and Chul Kim, MD, MPH, discuss molecular assays and treatment options ...

Integrated care involving medication and intensive counseling showed effectiveness for smoking cessation among adults ...

Self-reported tobacco abstinence was greater at both 3 and 6 months with higher levels of integration of smoking cessation ...

Lung cancer remains a leading cause of cancer-related deaths worldwide, demanding focused attention and unwavering commitment ...

Insights from a study on GLP-1 receptor agonists reveal benefits for cardiometabolic health, with notable risks for ...

During a Community Case Forum event in partnership with the Medical Oncology Association of Southern California, Edward S.